Catalog Number | GTX96707 |
Product Name | FABP3 antibody |
Product Description | Mouse polyclonal to FABP3 |
Synonyms | FABP11, H-FABP, MDGI, O-FABP |
Background | The intracellular fatty acid-binding proteins (FABPs) belongs to a multigene family. FABPs are divided into at least three distinct types, namely the hepatic-, intestinal- and cardiac-type. They form 14-15 kDa proteins and are thought to participate in the uptake, intracellular metabolism and/or transport of long-chain fatty acids. They may also be responsible in the modulation of cell growth and proliferation. Fatty acid-binding protein 3 gene contains four exons and its function is to arrest growth of mammary epithelial cells. This gene is a candidate tumor suppressor gene for human breast cancer. |
Clonality | Polyclonal |
Host | Mouse |
Immunogen | FABP3 (AAH07021, 1 a.a. ~ 134 a.a) full length recombinant protein with GST tag. |
Antigen Species | Human |
Tested Applications | ELISA, Western blot. The usefulness of this product in other applications has not been determined. |
Application Note | For ELISA (tested with immunogen): Use at an assay dependednt dilution. For WB: (tested against immunogen): Use at an assay dependednt dilution. Not tested in other applications. Optimal dilutions/concentrations should be determined by the researcher. |
Specificity | Not tested |
Species Cross Reactivity | Human - Not yet tested in other species |
Positive Controls | Recombinant protein |
Target | FABP3 |
Form Supplied | Liquid |
Purification | Unpurified |
Purification Note | From polyclonal serum |
Storage Buffer | Antiserum containing 50% glycerol |
Storage Instruction | Upon Receipt - Keep as concentrated solution. Aliquot and store at -20¨¬C or below. Avoid freeze-thaw cycles. |
Notes | Antibody reactive against recombinant protein with GST tag on ELISA. Please enquire about availability of recombinant protein. |
Manufacturer & Mfg Part# | Abnova H00002170-A01Only available to US end-users. Not available outside of the US or for resale inside of the US. |